T
Tensha Therapeutics
Small molecule selective bromodomain inhibitors for treating cancer and other diseases
About Tensha Therapeutics
Tensha Therapeutics is a biopharmaceutical company focused on developing innovative therapies to address unmet medical needs in oncology and rare diseases. The company operates in the highly specialized field of drug development, targeting specific patient populations with limited treatment options. Tensha Therapeutics employs a business model centered around research and development (R&D), leveraging cutting-edge science to create novel therapeutic solutions. The company generates revenue through partnerships, licensing agreements, and eventual commercialization of its proprietary drugs. Tensha Therapeutics serves a global market, primarily collaborating with healthcare providers, research institutions, and pharmaceutical companies. By focusing on niche markets with high medical needs, the company aims to bring transformative treatments to patients, thereby improving their quality of life.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Employees
- 1
- Open positions
- None listed
- Dealroom signal
- 59.5/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Testing, Biotechnology, Oncology, Spinout, Biotech and Pharma, medical testing, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- B2B
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Jan 2016 | $535M | $535M | Roche | — |
| EARLY VCEquity / VC | Apr 2012 | $0 | — | Undisclosed | — |
Growth signals
Latest recorded traffic for Tensha Therapeutics is 0 monthly website visits. Tensha Therapeutics's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Tensha Therapeutics in the Cambridge ecosystem
The Tensha Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
- HVHealthCare Ventures
Other known investors2 additional known investors
Dana-Farber Cancer Institute
Roche
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Tensha Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Tensha Therapeutics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








